$2.27 0.9%
AKAN Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Akanda

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products for medicinal use worldwide.


Akanda
Price $2.27
Target Price Sign up
Volume 347,730
Market Cap $4.3M
Year Range $2.18 - $20.4
Dividend Yield 0%
Industry Drug Manufacturers

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q4 '2300000
Q3 '23380,000790,000-410,000-13M-990,000
Q2 '231.4M4.2M-2.8M-5.9M-3.8M
Q1 '23700,000230,000470,000-2.9M-1.9M
Q4 '2273,0007.5M-7.4M-2.6M-9.4M

Insider Transactions View All

No recorded Insider transactions.

What is the Market Cap of Akanda?

The Market Cap of Akanda is $4.3M.

What is the current stock price of Akanda?

Currently, the price of one share of Akanda stock is $2.27.

How can I analyze the AKAN stock price chart for investment decisions?

The AKAN stock price chart above provides a comprehensive visual representation of Akanda's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Akanda shares. Our platform offers an up-to-date AKAN stock price chart, along with technical data analysis and alternative data insights.

Does AKAN offer dividends to its shareholders?

As of our latest update, Akanda (AKAN) does not offer dividends to its shareholders. Investors interested in Akanda should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Akanda?

Some of the similar stocks of Akanda are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.